Steroid use in elderly critically ill COVID-19 patients
Jung, Christian (Heinrich-Heine-University Duesseldorf)
Wernly, Bernhard (Paracelsus Medical University)
Fjølner, Jesper (Aarhus University Hospital (Aarhus, Dinamarca))
Bruno, Raphael Romano (Heinrich-Heine-University Duesseldorf)
Dudzinski, David (Massachusetts General Hospital (Boston))
Artigas Raventós, Antoni (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT))
Pinto, Bernardo Bollen (Geneva University Hospitals (Suïssa))
Schefold, Joerg C. (University of Bern)
Wolff, Georg (Heinrich-Heine-University Duesseldorf)
Kelm, Malte (Heinrich-Heine-University Duesseldorf)
Beil, Michael (Hebrew University of Jerusalem)
Sigal, Sviri (Hebrew University of Jerusalem)
van Heerden, Peter Vernon (Hebrew University of Jerusalem)
Szczeklik, Wojciech (Jagiellonian University Medical College)
Czuczwar, Miroslaw (Medical University of Lublin)
Elhadi, Muhammed (University of Tripoli)
Joannidis, Michael (Medical University Innsbruck)
Oeyen, Sandra (Ghent University Hospital (Bèlgica))
Zafeiridis, Tilemachos (General University Hospital of Larissa (Grècia))
Marsh, Brian (Mater Misericordiae University Hospital(Dublín, Irlanda))
Andersen, Finn H. (Norwegian university of Science and Technology)
Moreno, Rui (Centro Hospitalar Universitário de Lisboa Central)
Cecconi, Maurizio (Humanitas University (Itàlia))
Leaver, Susannah (St Georgés University Hospitals NHS Foundation trust)
Boumendil, Ariane (Hôpital Saint-Antoine (França))
De Lange, Dylan W.. (University Utrecht)
Guidet, Bertrand (Hôpitaux de Paris)
Flaatten, Hans (Haukeland University Hospital (Noruega))
Universitat Autònoma de Barcelona

Date:	2021
Abstract:	More than a year after the onset of the SARS-Cov-2 pandemic, treating patients with COVID-19 remains a challenge. By contrast to the rapid development of effective vaccines against SARS-Cov-2, the development of specific and effective therapeutics against COVID-19 remains largely unresolved. This secondary analysis of the COVIP study shows a higher 30-day-mortality in critically ill elderly COVID-19 patients who received steroids as part of their treatment.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Published in:	European respiratory journal, june 2021, ISSN 1399-3003

DOI: 10.1183/13993003.00979-2021
PMID: 34172464

9 p, 614.7 KB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Parc Taulí Research and Innovation Institute (I3PT
Articles > Research articles
Articles > Published articles